Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ana Fernández-Rodríguez

2PUBLICATIONS

11CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 06, 2026

RAF1 as a standalone therapeutic target in KRAS-driven lung adenocarcinoma: No added efficacy from co-targeting ARAF, EGFR, or DDR1.

Laura de-la-Puente-Ovejero, Ana Fernández-Rodríguez, Sarah Francoz

|Aug 26, 2024

Type I interferon signaling pathway enhances immune-checkpoint inhibition in KRAS mutant lung tumors.

Fernando Fernández-García, Ana Fernández-Rodríguez, Coral Fustero-Torre

Pageof 1

Frequent Collaborators

2 joint publications

Monica Musteanu

1 joint publications

Fernando Fernández-García

1 joint publications

Elena Piñeiro-Yáñez

1 joint publications

Sergio Callejas

1 joint publications

Rebeca Álvarez

1 joint publications

Carmen Guerra

1 joint publications

Chiara Ambrogio

1 joint publications

Ana Dopazo

1 joint publications

Mariano Barbacid

1 joint publications

Laura de-la-Puente-Ovejero

Frequent Collaborators

2 joint publications

Monica Musteanu

1 joint publications

Fernando Fernández-García

1 joint publications

Elena Piñeiro-Yáñez

1 joint publications

Sergio Callejas

Top Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on : Dec 01, 2016

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

See more related videos

Top Related Videos

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on : Dec 01, 2016

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Transfer of Manipulated Tumor-associated Neutrophils into Tumor-Bearing Mice to Study their Angiogenic Potential In Vivo

Published on : Jul 20, 2019

See more related videos